Publications by authors named "Darlene Rozewski"

Claim this Profile
D
Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice.
Jim H Hughes, Richard N Upton, Stephanie E Reuter, Darlene M Rozewski, Mitch A Phelps

Cancer Chemother Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced occurrence of tumor flare with flavopiridol followed by combined flavopiridol and lenalidomide in patients with relapsed chronic lymphocytic leukemia (CLL).
Kami Maddocks, Lai Wei, Darlene Rozewski, Yao Jiang, Yuan Zhao

Am J Hematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemia.
Kami Maddocks, Amy S Ruppert, Rebekah Browning, Jeffrey Jones, Joseph Flynn, Darlene M Rozewski

Leuk Res· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitive liquid chromatography/mass spectrometry methods for quantification of pomalidomide in mouse plasma and brain tissue.
Yao Jiang, Jiang Wang, Darlene M Rozewski, Shamalatha Kolli, Chia-Hsien Wu

J Pharm Biomed Anal· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics and tissue disposition of lenalidomide in mice.
Darlene M Rozewski, Sarah E M Herman, William H Towns, Emilia Mahoney, Matthew R Stefanovski

AAPS J· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of lenalidomide and CCI-779 in patients with relapsed multiple myeloma: evidence for lenalidomide-CCI-779 interaction via P-glycoprotein.
Craig C Hofmeister, Xiaoxia Yang, Flavia Pichiorri, Ping Chen, Darlene M Rozewski

J Clin Oncol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dose escalation of lenalidomide in relapsed or refractory acute leukemias.
William Blum, Rebecca B Klisovic, Heiko Becker, Xiaoxia Yang, Darlene M Rozewski

J Clin Oncol· November 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I clinical and pharmacokinetic study of a novel schedule of flavopiridol in relapsed or refractory acute leukemias.
William Blum, Mitch A Phelps, Rebecca B Klisovic, Darlene M Rozewski, Wenjun Ni

Haematologica· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential effects of IL-2 and IL-21 on expansion of the CD4+ CD25+ Foxp3+ T regulatory cells with redundant roles in natural killer cell mediated antibody dependent cellular cytotoxicity in chronic lymphocytic leukemia.
Aruna Gowda, Asha Ramanunni, Carolyn Cheney, Darlene Rozewski, Wayne Kindsvogel

MAbs· June 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel plant-derived agent silvestrol has B-cell selective activity in chronic lymphocytic leukemia and acute lymphoblastic leukemia in vitro and in vivo.
David M Lucas, Ryan B Edwards, Gerard Lozanski, Derek A West, Jungook D Shin, Darlene M Rozewski

Blood· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical response and pharmacokinetics from a phase 1 study of an active dosing schedule of flavopiridol in relapsed chronic lymphocytic leukemia.
Mitch A Phelps, Thomas S Lin, Amy J Johnson, Eunju Hurh, Darlene M Rozewski

Blood· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel liposomal formulation of flavopiridol.
Xiaojuan Yang, Xiaobin Zhao, Mitch A Phelps, Longzhu Piao, Darlene M Rozewski

Int J Pharm· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and validation of a sensitive liquid chromatography/mass spectrometry method for quantitation of flavopiridol in plasma enables accurate estimation of pharmacokinetic parameters with a clinically active dosing schedule.
Mitch A Phelps, Darlene M Rozewski, Jeffrey S Johnston, Katherine L Farley, Katie A Albanese

J Chromatogr B Analyt Technol Biomed Life Sci· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis